New Product Development and Launch Best Practices
Best Practices, LLC has conducted extensive research in the field of New Product Development and Launch. Browse through and sample our published New Product Development and Launch research in the topics below:
| |  | Top 5 Best Practices in Launching Blockbuster Drugs
This document contains five top practices in launching blockbuster drugs. The leading practices, managerial insights and benchmark metrics in this report are drawn from in-depth interviews with more than 24 executives at 12 leading pharmaceutical companies.
“Top Five Best Practices in Launching Blockbuster Drugs” includes a top practice from each of five functional areas identified through extensive research and interviews.
Toolkit for Communicating Clinical Trial Results: Activities & Timing 
This document contains an introduction and 13 graphics that outline the key steps in the process of communicating clinical trial results to physicians, the managed care community and consumers. It outlines specific activities recommended at each phase of a clinical study as well as pre-clinical and post-launch activities. The process of communicating clinical study results requires prioritization of key activities and careful coordination to ensure a long-lasting effect in the minds of these key audiences. Reading this document will allow you to carefully plan when each activity should start and end throughout the development process. This document is compiled from research done as part of Best Practices, LLC's consulting services.
Case Studies in Successful Re-Launch: Zithromax and Wellbutrin
Non-members: Click here to sign-up for a complimentary tour of
"Case Studies in Successful Re-Launch: Zithromax and Wellbutrin"
Study Overview
Successfully re-launching a pharmaceutical product is a difficult feat. However, two well-known pharmaceutical products were able to re-launch into major blockbusters. These case studies, described in detail in a 23-slide presentation, draw on primary and secondary research to illustrate how success was reached. Brand executives can use these case studies to learn how to spot the opportunities, tactics and strategies they need to turn their own re-launched products into major blockbusters.
Key topics
Causes for Re-Launch (e.g., initial sales performance, challenges faced)
Relaunch Decision Factors
Opportunities Seized
Pricing Changes
Sales Force Changes
Overcoming Internal Resistance
Specific Relaunch Tactics Used
Key Findings
Extensive market research on Zithromax revealed the price was too high. Combined with lowering the price, Pfizer was also able to deploy a different mix of sales people to promote it.
Psychiatrists and internal advocates pushed for Wellbutrin's return to the market, and Wellcome (before it was GlaxoWellcome or GSK) was able to establish that few people were at risk for seizures and put forth strong messages highlighting its strengths.
Methodology
This research was gleaned from a larger consulting project for a pharmaceutical client.
|
|